Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.72
22.11.22
-
22.11.23
-66.14%
23.11.23

Could be worthwhile Investment >10% per year
buy
Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA VZ

Start price
Target price
Perf. (%)
€12.00
21.11.22
€14.00
21.11.23
9.17%
24.07.23

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
buy
Voxeljet AG ADR

Start price
Target price
Perf. (%)
€2.92
20.11.22
€5.00
20.11.23
-34.59%
21.06.23

Could be worthwhile Investment >10% per year
Hive Digital Technologies Ltd.

Start price
Target price
Perf. (%)
€2.18
19.11.22
€2.00
19.11.23
-0.92%
11.01.23

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Bad culture
Bad rating
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.24
17.11.22
-
17.11.23
0.48%
26.12.22

Risky Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.62
16.11.22
€1.00
16.11.23
26.73%
23.01.23

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
Weng Fine Art AG NA

Start price
Target price
Perf. (%)
€13.95
16.11.22
-
16.11.23
-52.83%
17.11.23

buy
Agrogeneration

Start price
Target price
Perf. (%)
€0.077
15.11.22
€0.10
15.11.23
-77.33%
16.11.23

Could be worthwhile Investment >10% per year
buy
Santacruz Silver Mining

Start price
Target price
Perf. (%)
€0.38
14.11.22
€0.63
14.11.23
-15.94%
30.11.22

buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€6.75
14.11.22
€10.00
14.11.23
31.66%
17.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
German Startups Group Berlin Gmbh & Co KGaA

Start price
Target price
Perf. (%)
€1.64
14.11.22
-
14.11.23
-7.93%
15.11.23

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.80
14.11.22
-
14.11.23
-13.88%
28.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Hive Digital Technologies Ltd.

Start price
Target price
Perf. (%)
€2.52
14.11.22
-
14.11.23
-19.05%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Intica Systems AG

Start price
Target price
Perf. (%)
€8.25
13.11.22
€10.00
13.11.23
3.03%
26.11.22

Could be very worthwhile Investment >20% year
Strong uniques
Future proof or reliable business model
Very small cyclical dependencies
buy
Boost Issuer PLC

Start price
Target price
Perf. (%)
-
13.11.22
-
13.11.23
0.00%
14.11.23

buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.04
12.11.22
€4.50
12.11.23
5.82%
13.11.23

Could be worthwhile Investment >10% per year
buy
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€2.94
12.11.22
-
12.12.22
0.68%
13.12.22

Could be worthwhile Investment >10% per year
Uzabase Inc

Start price
Target price
Perf. (%)
€10.10
12.11.22
€4.00
12.11.23
0.99%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
EBIT decline/stagnation expected
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.96
12.11.22
€0.000
12.11.23
-17.89%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
ReneSola Ltd ADR

Start price
Target price
Perf. (%)
€4.61
11.11.22
-
11.11.23
9.76%
06.12.22

buy
Voxeljet AG ADR

Start price
Target price
Perf. (%)
€2.48
11.11.22
€4.00
11.11.23
16.53%
11.11.22

Could be worthwhile Investment >10% per year
Tritax Big Box REIT PLC

Start price
Target price
Perf. (%)
€1.52
06.11.22
€1.00
06.11.23
9.21%
12.11.22

Probably not worthwhile Investment
Decining EBIT margin than peer group
buy
Lexibook

Start price
Target price
Perf. (%)
€1.98
04.11.22
-
04.11.23
21.71%
05.11.23

Could be worthwhile Investment >10% per year
buy
Inpixon

Start price
Target price
Perf. (%)
€3.18
31.10.22
-
31.10.23
6.00%
12.11.22

Could be worthwhile Investment >10% per year
Very capable Management
Little innovation
buy
Sonnet Biotherapeutics Holdings Inc.

Start price
Target price
Perf. (%)
€1.57
31.10.22
-
31.10.23
74.57%
01.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques